(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATP5F1C mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:732617 6480464 1, 2-Dimethylhydrazine results in decreased expression of ATP5F1C mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:732617 6480464 Ethinyl Estradiol results in increased expression of ATP5F1C mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ATP5F1C mRNA CTD PMID:15212814 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ATP5F1C protein CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732616 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP5F1C mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732617 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ATP5F1C promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732617 6480464 Tetrachlorodibenzodioxin affects the expression of ATP5F1C mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP5F1C mRNA CTD PMID:18796159 4,4'-sulfonyldiphenol increases expression ISO RGD:732616 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ATP5F1C protein CTD PMID:34186270 5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid increases expression ISO RGD:732616 6480464 acipimox results in increased expression of ATP5F1C mRNA CTD PMID:25352640 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ATP5F1C mRNA CTD PMID:30047161 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ATP5F1C mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:732616 6480464 Aflatoxin B1 results in decreased methylation of ATP5F1C gene CTD PMID:27153756 amitrole increases expression EXP 6480464 Amitrole results in increased expression of ATP5F1C mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP5F1C mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:732616 6480464 Antimycin A results in decreased expression of ATP5F1C mRNA CTD PMID:33512557 arsenite(3-) multiple interactions ISO RGD:732616 6480464 arsenite promotes the reaction [G3BP1 protein binds to ATP5F1C mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:732616 6480464 Arsenic Trioxide results in increased expression of ATP5F1C mRNA CTD PMID:22521957 atrazine increases expression ISO RGD:732616 6480464 Atrazine results in increased expression of ATP5F1C mRNA CTD PMID:22378314 azoxystrobin decreases expression ISO RGD:732616 6480464 azoxystrobin results in decreased expression of ATP5F1C mRNA CTD PMID:33512557 benzatropine multiple interactions ISO RGD:732616 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of ATP5F1C protein CTD PMID:34122009 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP5F1C mRNA CTD PMID:30816183 bisphenol A decreases expression ISO RGD:732616 6480464 bisphenol A results in decreased expression of ATP5F1C protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:732616 6480464 bisphenol A results in decreased methylation of ATP5F1C gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:732616 6480464 bisphenol A affects the expression of ATP5F1C mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP5F1C mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:732616 6480464 bisphenol B results in increased expression of ATP5F1C protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:732616 6480464 bisphenol F results in increased expression of ATP5F1C protein CTD PMID:34186270 chloropicrin increases expression ISO RGD:732616 6480464 chloropicrin results in increased expression of ATP5F1C mRNA CTD PMID:26352163 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ATP5F1C protein CTD PMID:16470657 clofibrate increases expression ISO RGD:732617 6480464 Clofibrate results in increased expression of ATP5F1C mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:732617 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ATP5F1C mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATP5F1C mRNA] CTD PMID:17585979 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of ATP5F1C mRNA CTD PMID:30047161 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ATP5F1C mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ATP5F1C mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:732616 6480464 Copper Sulfate results in decreased expression of ATP5F1C mRNA CTD PMID:19549813 , PMID:20599845 copper(II) sulfate increases expression ISO RGD:732616 6480464 Copper Sulfate results in increased expression of ATP5F1C mRNA CTD PMID:20599845 Cuprizon multiple interactions ISO RGD:732616 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of ATP5F1C protein CTD PMID:34122009 cyclosporin A decreases expression ISO RGD:732616 6480464 Cyclosporine results in decreased expression of ATP5F1C mRNA CTD PMID:20106945 , PMID:25562108 deoxynivalenol decreases expression ISO RGD:732616 6480464 deoxynivalenol results in decreased expression of ATP5F1C protein CTD PMID:33890134 diarsenic trioxide increases expression ISO RGD:732616 6480464 Arsenic Trioxide results in increased expression of ATP5F1C mRNA CTD PMID:22521957 dibutyl phthalate decreases expression ISO RGD:732617 6480464 Dibutyl Phthalate results in decreased expression of ATP5F1C mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ATP5F1C mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:732616 6480464 dicrotophos results in decreased expression of ATP5F1C mRNA CTD PMID:28302478 doxorubicin increases expression ISO RGD:732616 6480464 Doxorubicin results in increased expression of ATP5F1C mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:732617 6480464 Doxorubicin results in decreased expression of ATP5F1C protein CTD PMID:34246718 fenpyroximate decreases expression ISO RGD:732616 6480464 fenpyroximate results in decreased expression of ATP5F1C mRNA CTD PMID:33512557 flutamide increases expression ISO RGD:732617 6480464 Flutamide analog results in increased expression of ATP5F1C mRNA, Flutamide results in increased expression of ATP5F1C mRNA CTD PMID:17702527 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ATP5F1C mRNA CTD PMID:24136188 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ATP5F1C mRNA CTD PMID:22061828 isotretinoin decreases expression ISO RGD:732616 6480464 Isotretinoin results in decreased expression of ATP5F1C mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:732616 6480464 Ivermectin results in decreased expression of ATP5F1C protein CTD PMID:32959892 lamivudine multiple interactions ISO RGD:732617 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5F1C mRNA CTD PMID:18313992 lead(0) affects splicing ISO RGD:732616 6480464 Lead affects the splicing of ATP5F1C mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:732616 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5F1C mRNA CTD PMID:31059760 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of ATP5F1C mRNA CTD PMID:22281203 methidathion affects expression ISO RGD:732617 6480464 methidathion affects the expression of ATP5F1C mRNA CTD PMID:34813904 methimazole increases expression EXP 6480464 Methimazole results in increased expression of ATP5F1C mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO RGD:732616 6480464 Methyl Methanesulfonate results in decreased expression of ATP5F1C mRNA CTD PMID:23649840 mitoxantrone decreases expression ISO RGD:732617 6480464 Mitoxantrone results in decreased expression of ATP5F1C protein CTD PMID:34246718 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of ATP5F1C mRNA CTD PMID:30316929 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of ATP5F1C mRNA CTD PMID:27638505 paracetamol decreases expression ISO RGD:732617 6480464 Acetaminophen results in decreased expression of ATP5F1C mRNA CTD PMID:15030884 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ATP5F1C protein CTD PMID:16538041 paracetamol affects expression ISO RGD:732617 6480464 Acetaminophen affects the expression of ATP5F1C mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:732617 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ATP5F1C mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATP5F1C mRNA] CTD PMID:17585979 paracetamol multiple interactions ISO RGD:732616 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5F1C mRNA CTD PMID:31059760 paracetamol decreases expression ISO RGD:732616 6480464 Acetaminophen results in decreased expression of ATP5F1C mRNA CTD PMID:29067470 , PMID:31059760 parathion increases expression ISO RGD:732617 6480464 Parathion results in increased expression of ATP5F1C mRNA CTD PMID:34813904 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732617 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ATP5F1C mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:732616 6480464 perfluorooctanoic acid results in increased expression of ATP5F1C mRNA CTD PMID:23978341 phenylpropanolamine decreases expression ISO RGD:732617 6480464 Phenylpropanolamine results in decreased expression of ATP5F1C mRNA CTD PMID:16465460 phlorizin increases expression ISO RGD:732617 6480464 Phlorhizin results in increased expression of ATP5F1C mRNA CTD PMID:22538082 picoxystrobin decreases expression ISO RGD:732616 6480464 picoxystrobin results in decreased expression of ATP5F1C mRNA CTD PMID:33512557 resveratrol multiple interactions ISO RGD:732616 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP5F1C mRNA CTD PMID:23557933 resveratrol increases expression ISO RGD:732617 6480464 Resveratrol results in increased expression of ATP5F1C protein CTD PMID:25505154 rotenone decreases expression ISO RGD:732616 6480464 Rotenone results in decreased expression of ATP5F1C mRNA CTD PMID:33512557 rotenone increases expression ISO RGD:732617 6480464 Rotenone results in increased expression of ATP5F1C mRNA CTD PMID:17702527 silicon dioxide decreases expression ISO RGD:732617 6480464 Silicon Dioxide results in decreased expression of ATP5F1C mRNA CTD PMID:19073995 Soman decreases expression EXP 6480464 Soman results in decreased expression of ATP5F1C mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:732616 6480464 Sunitinib results in decreased expression of ATP5F1C mRNA CTD PMID:31533062 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ATP5F1C mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATP5F1C mRNA] CTD PMID:31150632 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of ATP5F1C protein CTD PMID:35544339 tolcapone affects binding EXP 6480464 Tolcapone binds to ATP5F1C protein CTD PMID:19783845 toluene affects expression EXP 6480464 Toluene affects the expression of ATP5F1C mRNA CTD PMID:21827849 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of ATP5F1C mRNA CTD PMID:17553608 triptonide increases expression ISO RGD:732617 6480464 triptonide results in increased expression of ATP5F1C mRNA CTD PMID:33045310 tungsten increases expression ISO RGD:732617 6480464 Tungsten results in increased expression of ATP5F1C mRNA CTD PMID:30912803 valproic acid decreases methylation ISO RGD:732616 6480464 Valproic Acid results in decreased methylation of ATP5F1C gene CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of ATP5F1C mRNA CTD PMID:29427782 vincristine decreases expression ISO RGD:732616 6480464 Vincristine results in decreased expression of ATP5F1C mRNA CTD PMID:23649840 vitamin E decreases expression ISO RGD:732616 6480464 Vitamin E results in decreased expression of ATP5F1C mRNA CTD PMID:19244175 zidovudine multiple interactions ISO RGD:732617 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5F1C mRNA CTD PMID:18313992